tiprankstipranks
Advertisement
Advertisement

HK:2696 Stock Latest News

Henlius Wins NMPA Nod to Start Trials of Cetuximab Biosimilar HLX05-N
Company AnnouncementsHenlius Wins NMPA Nod to Start Trials of Cetuximab Biosimilar HLX05-N
10h ago
2696
Henlius Starts Phase 1 Trial of HLX319, a Subcutaneous Pertuzumab-Trastuzumab Biosimilar in China
PremiumCompany Announcements
Henlius Starts Phase 1 Trial of HLX319, a Subcutaneous Pertuzumab-Trastuzumab Biosimilar in China
4d ago
2696
Henlius Wins China Nod to Expand Indications for Rituximab Biosimilar HANLIKANG
PremiumCompany Announcements
Henlius Wins China Nod to Expand Indications for Rituximab Biosimilar HANLIKANG
5d ago
2696
Henlius Wins NMPA Nod to Begin Trials of HER2 Breast Cancer Biosimilar HLX319
PremiumCompany Announcements
Henlius Wins NMPA Nod to Begin Trials of HER2 Breast Cancer Biosimilar HLX319
13d ago
2696
Henlius Wins NMPA Nod to Start Trials of Novel Hyaluronidase Injection
PremiumCompany Announcements
Henlius Wins NMPA Nod to Start Trials of Novel Hyaluronidase Injection
14d ago
2696
Henlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe
PremiumCompany AnnouncementsHenlius Wins Key EMA Backing for Cancer Drug Serplulimab in Europe
15d ago
2696
Henlius Starts Phase 1b/2 Trial of CD47-Targeting HLX701 in Advanced Colorectal Cancer
Premium
Company Announcements
Henlius Starts Phase 1b/2 Trial of CD47-Targeting HLX701 in Advanced Colorectal Cancer
19d ago
2696
Henlius Wins NMPA Nod for Phase 1 Trial of Nivolumab Biosimilar HLX18
Premium
Company Announcements
Henlius Wins NMPA Nod for Phase 1 Trial of Nivolumab Biosimilar HLX18
25d ago
2696
Henlius Boosts 2025 Revenue as Global Drug Approvals Broaden Its Biologic Portfolio
PremiumCompany Announcements
Henlius Boosts 2025 Revenue as Global Drug Approvals Broaden Its Biologic Portfolio
25d ago
2696
Henlius Taps Fosun Affiliate to Promote HANBEITAI in Connected-Party Deal
PremiumCompany Announcements
Henlius Taps Fosun Affiliate to Promote HANBEITAI in Connected-Party Deal
25d ago
2696
Shanghai Henlius revamps Hong Kong company secretary and governance roles
PremiumCompany Announcements
Shanghai Henlius revamps Hong Kong company secretary and governance roles
25d ago
2696
Henlius Wins NMPA Nod for Novel Lung Cancer Combination Trial
PremiumCompany Announcements
Henlius Wins NMPA Nod for Novel Lung Cancer Combination Trial
29d ago
2696
Henlius Wins NMPA Nod to Launch First-in-Class HLX316 Cancer Trial
PremiumCompany AnnouncementsHenlius Wins NMPA Nod to Launch First-in-Class HLX316 Cancer Trial
1M ago
2696
Henlius Wins NMPA Clearance to Begin Trials of First-in-Class Tetra-Specific Cancer Antibody HLX3901
Premium
Company Announcements
Henlius Wins NMPA Clearance to Begin Trials of First-in-Class Tetra-Specific Cancer Antibody HLX3901
1M ago
2696
Henlius Wins NMPA Clearance to Begin First-in-Human Trial of Novel KAT6 Inhibitor HLX97
Premium
Company Announcements
Henlius Wins NMPA Clearance to Begin First-in-Human Trial of Novel KAT6 Inhibitor HLX97
1M ago
2696
Shanghai Henlius Biotech Sets March Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Shanghai Henlius Biotech Sets March Board Meeting to Approve 2025 Results
1M ago
2696
Henlius Starts Phase 2/3 Trial of HLX22-HLX87 Combo in HER2-Positive Metastatic Breast Cancer
PremiumCompany Announcements
Henlius Starts Phase 2/3 Trial of HLX22-HLX87 Combo in HER2-Positive Metastatic Breast Cancer
2M ago
2696
Henlius Wins Key EMA Backing for Pertuzumab Biosimilar HLX11 in Europe
PremiumCompany Announcements
Henlius Wins Key EMA Backing for Pertuzumab Biosimilar HLX11 in Europe
2M ago
2696
Henlius Reshapes Global Licensing Strategy for HANSIZHUANG With Abbott and KGBio
PremiumCompany Announcements
Henlius Reshapes Global Licensing Strategy for HANSIZHUANG With Abbott and KGBio
2M ago
2696
Henlius Wins U.S. FDA IND Nod for Multiple Myeloma Biosimilar HLX15-SC
PremiumCompany AnnouncementsHenlius Wins U.S. FDA IND Nod for Multiple Myeloma Biosimilar HLX15-SC
2M ago
2696
Henlius Wins NMPA Nod to Start Trials of Daratumumab Biosimilar HLX15-SC
Premium
Company Announcements
Henlius Wins NMPA Nod to Start Trials of Daratumumab Biosimilar HLX15-SC
2M ago
2696
Henlius Starts Phase 1b/2 Trial of HLX43 Combinations in Advanced Colorectal Cancer
Premium
Company Announcements
Henlius Starts Phase 1b/2 Trial of HLX43 Combinations in Advanced Colorectal Cancer
2M ago
2696

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >